Nick Pizzie, Chief Financial Officer at Axsome Therapeutics, Inc. (AXSM), sold 12,000 shares at $187.92 ($2.3M) on 2026-01-22, disclosed to the SEC on 2026-01-23.
Open-market sale of $2.3M AXSM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AXSM | BUY | 2021-11-22 | $34K | — | Filing → |
| AXSM | BUY | 2020-06-30 | $119K | — | Filing → |
| AXSM | BUY | 2019-09-30 | $54K | — | Filing → |